Clinical trial · Observational
Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence
NCT01707758CI-TRIAL-00010335withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Trial terminated - Nanoscale Company out of business
Summary
Brief summary (as posted)
The primary objective is to develop a rapid in vitro screening assay for detection of pancreatic cancer biomarkers in blood of patients with pancreatic cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- pancreatic cancer
- description
- This study will collect blood from 36 patients with known or suspected pancreatic cancer and from 12 healthy cancer-free subjects.
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Inclusion Criteria for Pancreatic Cancer Patients: * Patients will either have a histologic diagnosis of pancreatic carcinoma or a clinical picture consistent with pancreatic cancer and will be undergoing surgery or a diagnostic procedure to confirm the diagnosis. * Patients will have had no prior treatment or surgery Inclusion Criteria for Healthy Subjects: * Subjects will have no prior history of any cancer Exclusion Criteria: Exclusion Criteria for Pancreatic Cancer Patients * Any prior treatment for pancreatic cancer * Poorly controlled diabetes Exclusion Criteria for Healthy Subjects * Poorly controlled diabetes
References
Publications (0)
Data not yet available
No reference posted for this study.